HOME >> MEDICINE >> NEWS
International trial of two microbicides begins

A large, multisite trial designed to examine the safety and preliminary effectiveness of two candidate topical microbicides to prevent HIV infection has opened to volunteer enrollment. The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, represents a partnership among various research institutions in Africa and the United States.

Although no licensed microbicides are available to the public currently, scientists hope these agents--designed to be applied to the surface of the vagina to prevent sexually transmitted infections (STIs)--will one day be a key tool in the fight against HIV/AIDS.

Women make up nearly half of all people living with HIV worldwide. "The majority of new cases of HIV infection in women result from heterosexual intercourse, but women may not always be able to insist that their male partners use measures to prevent HIV transmission," notes NIAID Director Anthony S. Fauci, M.D. "If effective, microbicides would be a valuable woman-controlled means of slowing the pace of the HIV/AIDS epidemic," Dr. Fauci adds.

The first volunteers were enrolled this week at sites in Durban, South Africa, and at the University of Pennsylvania in Philadelphia. Enrollment will begin shortly at sites in four additional African countries--Malawi, Tanzania, Zimbabwe and Zambia. Approximately 3,220 women will be enrolled in the trial, which is expected to last approximately 30 months.

"This is the first microbicide safety and effectiveness trial of this magnitude to be conducted by NIAID," says Roberta J. Black, Ph.D., Topical Microbicide Team Leader in NIAID's Division of AIDS. "It is a critical trial evaluating two topical microbicides with differing mechanisms of action," she adds.

The microbicides to be tested are PRO 2000 and BufferGel. Produced by Indevus Pharmaceuticals, Lexington, MA, PRO 2000 has shown activity against HIV and other STIs in bot
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
11-Feb-2005


Page: 1 2

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. National Academies advisory: May 2 Symposium on International Science Policy
3. Awards & fellowships at the International & American Association for Dental Research General Session
4. Lectures, keynoters, symposia highlight International Dental Research meeting
5. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
6. International gathering of experts to share retinoblastoma breakthroughs
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic ... in Medicare Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction ... Health Records (EHR) integration at the point of care to providers and ...
(Date:7/17/2019)... ... July 17, 2019 , ... This past Saturday, Monarch Dental® hosted ... . Over 50 underserved patients were welcomed at the Mesquite office to receive free ... summer season. Individuals were referred to the event through local nonprofit organizations such as ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... Women’s Excellence is pleased to announce a ... summer in September. The new offices resides on the corner of Turrill Road and ... We are thrilled about the opening of our new office in Lapeer and the ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... of its proprietary patient management platform, Ospitek “View”. Ospitek has partnered with some ... deliver a fully customizable, intelligent, solution made specifically for surgical centers, allowing them ...
(Date:7/12/2019)... SCOTCH PLAINS, N.J. (PRWEB) , ... July 12, 2019 , ... ... been reviewed and approved by NJ Top Docs for 2019. Located in Paramus, BAXT ... has been providing state-of-the-art cosmetic and medical dermatological care for the past 45 years. ...
Breaking Medicine News(10 mins):
(Date:7/11/2019)... ... July 11, 2019 , ... Voted one of ... and considered by a luminary of the cosmetic world to “represent a revolutionary ... Sciadonic Acid DELTA-5, derived from exotic conifer seeds. DELTA-5 technology works to reduce ...
(Date:7/11/2019)... JERSEY CITY, N.J. (PRWEB) , ... July 11, ... ... at Indiana MGMA , GRM Information Management, a leading provider of enterprise content ... Annual Conference in French Lick, Indiana July 17 to July 19. , ...
(Date:7/11/2019)... ... July 11, 2019 , ... Twenty-one ... among Castle Connolly’s Top Doctors. All of these professionals are recognized as Atlanta’s ... physicians in the publication’s urology category and all of the physicians in the ...
Breaking Medicine Technology:
Cached News: